STREAMEX CORP. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- STREAMEX CORP. stock issued during period, value, other for the quarter ending 2025-03-31 was $818.00K, a 21.35% decline year-over-year.
- STREAMEX CORP. stock issued during period, value, other for the quarter ending 2024-06-30 was $636.00K, a 80.40% decline year-over-year.
- STREAMEX CORP. stock issued during period, value, other for the quarter ending 2024-03-31 was $1.04M, a 84.59% decline year-over-year.
- STREAMEX CORP. stock issued during period, value, other for the quarter ending 2023-09-30 was $2.62M.
- STREAMEX CORP. stock issued during period, value, other for fiscal 2025 was $818.00K, a 80.57% decline from fiscal 2024.
- STREAMEX CORP. stock issued during period, value, other for fiscal 2024 was $4.21M, a 72.49% decline from fiscal 2023.
- STREAMEX CORP. stock issued during period, value, other for fiscal 2023 was $15.30M, a 84.73% increase from fiscal 2022.
- STREAMEX CORP. stock issued during period, value, other for fiscal 2022 was $8.28M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-12-31 | $818.00K 10-K · filed 2026-03-31 | |
| 2025-03-31 | $818.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $4.21M 10-K · filed 2026-03-31 | |
| 2024-06-30 | $636.00K 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $1.04M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $15.30M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $2.62M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $3.25M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $6.75M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $8.28M 10-K · filed 2024-04-16 | |
| 2022-06-30 | $2.82M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $3.00M 10-Q · filed 2023-11-14 | |
| 2019-12-31 | $3.16M 10-K · filed 2021-03-15 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $3.39M derived: sum of 4 quarters · filed 2018-11-02 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $3.40M derived: sum of 4 quarters · filed 2018-07-27 |
| 2018-03-31 | $1.49M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.93M 10-K · filed 2018-02-27 |
| 2017-09-30 | $7.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $65.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |